techrockies
High Technology News and Information for the Rocky Mountain Region

Home
Mobile
News and Events
  • Headlines
  • Events
  • Members Only
  • Dealflow
  • Companies
  • Investors
  • People
  • Exits
  • PowerSearch
  • Statistics
  • About
  • Membership
  • About
  • Contact Us

  • Search News
    Monday, March 17, 2008

    Axial Adds $6M To Series B

    Axial Biotech Inc., a developer of DNA-based diagnostic tests for common spinal diseases, announced Monday that its second round of venture financing has received a $6 million tranche. The additional funding in the firm's Series B follows a $15.3M investment in the same round in March of last year. Axial credited the Johnson & Johnson Development Corp. with leading the effort. vSpring Capital and the Ohio Biotech Group also participated. Axial noted that the funding came on the heels of the company having met several major scientific milestones in the development of a genetic prognostic test for Adolescent Idiopathic Scoliosis. Axial said it expects to launch its AIS diagnostic test in September. Founded in 2002, Axial Biotech is headquartered in Salt Lake City, Utah.
    posted on Monday, March 17, 2008 (Link to more information)


    Related companies:
    Axial Biotech

    Related stories:
    > Axial Biotech Gets Bridge Round
    > Axial Biotech Installs Olson as Sales, Marketing EVP
    > Axial Biotech Raises $15.3M in Series B Funds
    > GlobeImmune Adds To Series B
    > Enerpulse Adds $5M To Series B Round

    RSS Email Twitter

    Sign up to receive updates via our daily email newsletter

    Enter your email:

    Previous Issues

    Friday, November 21, 2008
    Thursday, November 20, 2008
    Wednesday, November 19, 2008
    Tuesday, November 18, 2008
    Monday, November 17, 2008